Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Fosphenytoin Loading Dose
NCT00908453Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- May 2009
- Primary completion
- Feb 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosphenytoin in epilepsy, status epilepticus (SE), sponsored by Nobelpharma Co., Ltd.. Started May 2009; status: completed.
02
Drugs
fosphenytoin
03
Conditions
epilepsystatus epilepticus (SE)
Beyond the preview
Go deeper on NCT00908453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908453.